NCT03878082View on ClinicalTrials.gov

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

December 30, 2022

Study Completion Date

December 31, 2022

Conditions
Uterine Pain
Interventions
DRUG

Propacetamol 1g

pain control with IVPCA and propacetamol 1g every 6 hours for 2 days

DRUG

Propacetamol 2g

pain control with IVPCA and propacetamol 2g every 6 hours for 2 days

DRUG

IVPCA

pain control with IVPCA

Trial Locations (1)

104

MacKay Memorial Hospital, Taipei

All Listed Sponsors
lead

Mackay Memorial Hospital

OTHER

NCT03878082 - Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain | Biotech Hunter | Biotech Hunter